Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories

Journal of Medical Virology

Volumn 89, Issue 1, 2017, Pages 139-145

  Liao, Hao ^a   Li, Xiaodong ^a   Liu, Yan ^a   Xu, Zhihui ^a   Huang, Pengyu ^b   Nian, Xueyuan ^a   Liu, Xinguang ^b,c   Xu, Dongping ^a,b  

^a BEIJING 302 HOSPITAL   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Key Laboratory for Medical Molecular Diagnostics of Guangdong Province   (China)

Author keywords

clinical relevance; complete genome; hepatitis B virus; intergenotype; recombination

Indexed keywords

VIRUS DNA;

ACUTE HEPATITIS B; ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CHINA; CHRONIC HEPATITIS B; CLINICAL FEATURE; CLONAL EVOLUTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HYBRID GENE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PHYLOGENY; PROMOTER REGION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETIC RECOMBINATION; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREVALENCE; VIROLOGY; VIRUS LOAD;

ADULT; CHINA; DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIRUS REPLICATION;

EID: 84978995712     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24609     Document Type: Article

References (31)

1. Andernach IE, Jutavijittum P, Samountry B, Yousukh A, Thammavong T, Hbschen JM, Muller CP. 2012. A high variability of mixed infections and recent recombinations of hepatitis B virus in Laos. PLoS ONE 7:e30245.
2. Araujo NM, Waizbort R, Kay A. 2011. Hepatitis B virus infection from an evolutionary point of view: How viral, host, and environmental factors shape genotypes and subgenotypes. Infect Genet Evol 11:1199–1207.
3. Araujo NM. 2015. Hepatitis B virus intergenotypic recombinants worldwide: An overview. Infect Genet Evol 11:MEEGID-02453.
4. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. 2002. Genotype H: A new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073.
5. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C. J GenVirol 87:39–49.
6. Cui C, Shi J, Hui L, Xi H, Hu G. 2002. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. J Gen Virol 83:2773–2777.
7. Ji D, Liu Y, Si LI, Li L, Chen GF, Xin SJ, Zhao JM, Xu D. 2011. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients. Clin Chim Acta 412:305–313.
8. Ji D, Liu Y, Li L, Xu Z, Si L, Dai J, Li X, Wang L, Yao Z, Xin S, Chen G, Xu D. 2012. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation. J Clin Virol 54:66–72.
9. Li X, Wang L, Zhong Y, Wong VWS, Xu Z, Liu Y, Li Q, Xing S, Zhao J, Xu D. 2010. Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients. J Clin Microbiol 48:4363–4369.
10. Li X, Liu Y, Xu, Wan Z, Bai S, Mao P, Mao Y, Xin S, Xu D. 2013. A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations. J Med Virol 85:1698–1704.
11. Liu Y, Xu Z, Wang Y, Li X, Liu L, Chen L, Xin S, Xu D. 2014. RtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virus. PLoS ONE 9:e89015.
12. Liu Y, Li X, Xin S, Xu Z, Chen R, Yang J, Liu L, Wong VWS, Yang D, Chan HLY, Xu D. 2015. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil. J Viral Hepat 22:328–334.
13. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin AA, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CR, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study. Lancet 380:2095–2128.
14. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP. 2008. Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 14:1777–1780.
15. Pérez-Losada M, Arenas M, Galán JC, Palero F, González-Candelas F. 2015. Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences. Infect Genet Evol 30:296–307.
16. Schultz AZ, Bulla I, Abdou-Chekaraou M, Gordien E, Morgenstern B, Zoulim F, Deny P, Stanke M. 2012. JpHMM: Recombination analysis in viruses with circular genomes such as the hepatitis B virus. Nucleic Acids Res 40:W193–W198.
17. Shen L, Yin W, Zheng H, Cui F, Zhang S, Wang F, Wang F, Zhang Y, Liang X, Bi S. 2014. Molecular epidemiological study of hepatitis B virus genotypes in Southwest, China. J Med Virol 86:1307–1313.
18. Shi W, Carr MJ, Dunford L, Zhu C, Hall WW, Higgins DG. 2012a. Identification of novel intergenotypic recombinants of human hepatitis B viruses by large-scale phylogenetic analysis. Virology 427:51–59.
19. Shi W, Zhu C, Zheng W, Zheng W, Ling C, Carr MJ, Higgins DG, Zhang Z. 2012b. Subgenotyping of genotype C hepatitis B virus: Correcting misclassifications and identifying a novel subgenotype. PLoS ONE 7:e47271.
20. Shi W, Zhang Z, Ling C, Zheng W, Zhu C, Carr MJ, Higgins DG. 2013. Hepatitis B virus subgenotyping: History, effects of recombination, misclassifications, and corrections. Infect Genet Evol 16:355–361.
21. Shi YH. 2012. Correlation between hepatitis B virus genotypes and clinical outcomes. Jpn J Infect Dis 65:476–482.
22. Simmonds P, Midgley S. 2005. Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 79:15467–15476.
23. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Ueda R, Miyakawa Y, Mizokami M. 2002. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 76:5985–5992.
24. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. 2009. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 83:10538–10547.
25. Tong W, He J, Sun L, He S, Qi Q. 2012. Hepatitis B virus with a proposed genotype I was found in Sichuan province, China. J Med Virol 84:866–870.
26. Wang Z, Huang Y, Wen S, Zhou B, Hou J. 2007. Hepatitis B virus genotypes and subgenotypes in China. Hepatol Res 37:S36–S41.
27. Wang LJ, Xu YF, Liu XX, Chen Y. 2015. Single-nucleotide substitution of hepatitis B virus in intrauterine infection. J Viral Hepat 22:433–440.
28. Xu Z, Wu G, Li F, Bai J, Xing W, Zhang D, Zeng C. 2013. Positive selection signals of hepatitis B virus and their association with disease stages and viral genotypes. Infect Genet Evol 19:176–187.
29. Yang, Xing K, Deng R, Wang J, Wang X. 2006. Identification of hepatitis B virus putative intergenotype recombinants by using fragment typing. J Gen Virol 87:2203–2215.
30. Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, Chen QR, Zhang J, Chen PJ, Xia NS. 2010. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype “I”. PLoS ONE 5:e9297.
31. Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J. 2005. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12:609–617.